Ignite Creation Date:
2024-05-05 @ 11:19 PM
Last Modification Date:
2024-10-26 @ 10:32 AM
Study NCT ID:
NCT01304147
Status:
COMPLETED
Last Update Posted:
2017-02-08
First Post:
2011-02-23
Brief Title:
Intranasal Ketamine in Treatment-Resistant Depression
Sponsor:
James Murrough
Organization:
Icahn School of Medicine at Mount Sinai
Study Overview
Official Title:
Intranasal IN Ketamine in Treatment-Resistant Depression TRD
Status:
COMPLETED
Status Verified Date:
2016-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of the current study is to investigate the safety and efficacy of a single dose of intranasal IN ketamine in treatment-resistant depression TRD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| INKET-001 | None | None | None |